N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning.

IF 1.3 Q4 PHARMACOLOGY & PHARMACY
Santiago Nogué-Xarau, Lidia Martínez-Sánchez, Milagros García-Peláez, Edurne Fernández de Gamarra-Martínez, Núria Pi-Sala, Àngels Gispert-Ametller, Emilio Salgado-García, Raquel Aguilar-Salmerón
{"title":"N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning.","authors":"Santiago Nogué-Xarau, Lidia Martínez-Sánchez, Milagros García-Peláez, Edurne Fernández de Gamarra-Martínez, Núria Pi-Sala, Àngels Gispert-Ametller, Emilio Salgado-García, Raquel Aguilar-Salmerón","doi":"10.1016/j.farma.2025.07.005","DOIUrl":null,"url":null,"abstract":"<p><p>Acetaminophen is one of the most widely used drugs in clinical practice due to its analgesic and antipyretic properties. However, overdose is one of the leading causes of severe acute liver failure. N-acetylcysteine, introduced as an antidote in 1974, has revolutionized the management of this intoxication by reducing hepatotoxicity and mortality associated with acetaminophen toxicity. At the end of the 19th century, acetaminophen was identified as the main active metabolite of phenacetin and acetanilide. Its therapeutic use began to gain popularity in the 1950s and later became one of the main drugs involved in suicide attempts, particularly among adolescents and young adults. Acetaminophen-induced hepatotoxicity was first described in 1966, establishing that an overdose could lead to fulminant hepatic necrosis. In 1975, Rumack and Matthew published a nomogram that allowed stratification of hepatic toxicity risk based on plasma drug levels. The mechanism of hepatotoxicity was elucidated in the early 1970s when it was discovered that acetaminophen is metabolized by cytochrome P450 into a highly reactive intermediate, N-acetyl-p-benzoquinoneimine, which is normally neutralized by hepatic glutathione. In overdose situations, glutathione depletion leads to hepatic necrosis. Based on these findings, sulfhydryl-containing agents such as cysteamine and methionine were introduced as antidotes, but N-acetylcysteine ultimately proved to be the most effective treatment. Since its introduction, N-acetylcysteine administration protocols have evolved to optimize efficacy and minimize adverse effects. Protocols such as the Scottish and Newcastle Acetylcysteine Protocol and the Two Bags regimen have simplified dosing and reduced the incidence of anaphylactoid reactions. Over the past 50 years, N-acetylcysteine has saved thousands of lives and remains the gold-standard antidotal treatment for acetaminophen poisoning.</p>","PeriodicalId":45860,"journal":{"name":"FARMACIA HOSPITALARIA","volume":" ","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FARMACIA HOSPITALARIA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.farma.2025.07.005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Acetaminophen is one of the most widely used drugs in clinical practice due to its analgesic and antipyretic properties. However, overdose is one of the leading causes of severe acute liver failure. N-acetylcysteine, introduced as an antidote in 1974, has revolutionized the management of this intoxication by reducing hepatotoxicity and mortality associated with acetaminophen toxicity. At the end of the 19th century, acetaminophen was identified as the main active metabolite of phenacetin and acetanilide. Its therapeutic use began to gain popularity in the 1950s and later became one of the main drugs involved in suicide attempts, particularly among adolescents and young adults. Acetaminophen-induced hepatotoxicity was first described in 1966, establishing that an overdose could lead to fulminant hepatic necrosis. In 1975, Rumack and Matthew published a nomogram that allowed stratification of hepatic toxicity risk based on plasma drug levels. The mechanism of hepatotoxicity was elucidated in the early 1970s when it was discovered that acetaminophen is metabolized by cytochrome P450 into a highly reactive intermediate, N-acetyl-p-benzoquinoneimine, which is normally neutralized by hepatic glutathione. In overdose situations, glutathione depletion leads to hepatic necrosis. Based on these findings, sulfhydryl-containing agents such as cysteamine and methionine were introduced as antidotes, but N-acetylcysteine ultimately proved to be the most effective treatment. Since its introduction, N-acetylcysteine administration protocols have evolved to optimize efficacy and minimize adverse effects. Protocols such as the Scottish and Newcastle Acetylcysteine Protocol and the Two Bags regimen have simplified dosing and reduced the incidence of anaphylactoid reactions. Over the past 50 years, N-acetylcysteine has saved thousands of lives and remains the gold-standard antidotal treatment for acetaminophen poisoning.

n -乙酰半胱氨酸:50 自从发现一种改变对乙酰氨基酚中毒预后的解毒剂以来。
对乙酰氨基酚具有镇痛解热作用,是临床应用最广泛的药物之一。然而,过量服用是导致严重急性肝衰竭的主要原因之一。n -乙酰半胱氨酸于1974年作为解毒剂引入,通过降低对乙酰氨基酚毒性相关的肝毒性和死亡率,彻底改变了这种中毒的管理。19世纪末,对乙酰氨基酚被确定为非那西丁和乙酰苯胺的主要活性代谢物。它的治疗用途在20世纪50年代开始流行,后来成为自杀企图的主要药物之一,特别是在青少年和年轻人中。对乙酰氨基酚引起的肝毒性在1966年首次被描述,确定过量服用可导致暴发性肝坏死。1975年,Rumack和Matthew发表了一个基于血浆药物水平的肝毒性风险分层的nomogram。对乙酰氨基酚的肝毒性机制在20世纪70年代初被阐明,当时发现对乙酰氨基酚被细胞色素P450代谢成一种高活性的中间体n -乙酰基-对苯醌亚胺,通常被肝谷胱甘肽中和。在过量的情况下,谷胱甘肽耗竭导致肝坏死。基于这些发现,含巯基的药物如半胱胺和蛋氨酸被引入作为解毒剂,但n -乙酰半胱氨酸最终被证明是最有效的治疗方法。自引入以来,n -乙酰半胱氨酸给药方案已经发展到优化疗效和最小化不良反应。方案,如苏格兰和纽卡斯尔乙酰半胱氨酸方案和两袋方案,简化了剂量,减少了类过敏反应的发生率。在过去的50 年里,n -乙酰半胱氨酸挽救了成千上万的生命,并且仍然是对乙酰氨基酚中毒的金标准解毒剂治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
FARMACIA HOSPITALARIA
FARMACIA HOSPITALARIA PHARMACOLOGY & PHARMACY-
CiteScore
1.90
自引率
21.40%
发文量
46
审稿时长
37 days
期刊介绍: Una gran revista para acceder a los mejores artículos originales y revisiones de la farmacoterapia actual. Además, es Órgano de expresión científica de la Sociedad Española de Farmacia Hospitalaria, y está indexada en Index Medicus/Medline, EMBASE/Excerpta Médica, Alert, Internacional Pharmaceutical Abstracts y SCOPUS.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信